Top

International Journal of Colorectal Disease

Published in:

01-12-2013 | Original Article

The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer

Authors: Basem Azab, Shiksha Kedia, Neeraj Shah, Steven Vonfrolio, William Lu, Ali Naboush, Farhan Mohammed, Scott W. Bloom

Published in: International Journal of Colorectal Disease | Issue 12/2013

Abstract

Background

Low serum albumin was found as a predictor of long-term mortality in colorectal cancer (CRC) patients. Our aim was to evaluate the value of the pretreatment albumin/globulin ratio (AGR) to predict the long-term mortality in CRC patients.

Methods

Patients were included if they had comprehensive metabolic panel (CMP) before treatment (surgery or chemotherapy). The albumin/globulin ratio, routinely reported in CMP, is calculated [AGR = Albumin/(Total protein − Albumin)]. Patients were divided into three equal tertiles according to their pretreatment AGR. The primary outcome was cancer-related mortality, which was obtained from our cancer registry database.

Results

A total of 534 consecutive CRC patients had pretreatment CMP. The 1st AGR tertile had a significant higher 4-year mortality compared to the second and third AGR tertiles (42 vs. 19 and 7 %, p < 0.0001 according to Fisher’s exact two-tailed test). In the multivariate model, AGR remained an independent predictor of survival with 75 % decrease in mortality among the highest AGR tertile in comparison to the lowest AGR tertile, p < 0.0001. In the subset of 234 patients with normal serum albumin (albumin of >3.5 g/dl), serum AGR continues to be an independent predictor of cancer-related mortality with an adjusted hazard ratio of the third tertile compared to the first tertile equal to 0.05 (95 % confidence interval 0.01–0.33, p = 0.002).

Conclusion

Low AGR was a strong independent predictor of long-term cancer-specific survival among colorectal cancer patients. Additionally, among the patients with normal albumin (>3.5 g/dl), patients with lower globulins but higher albumin and AGR levels had better survival.

American Cancer Society (2011) Colorectal cancer facts & figures 2011–2013. American Cancer Society, Atlanta

Betge J, Pollheimer MJ, Lindtner RA et al (2012) Intramural and extramural vascular invasion in colorectal cancer: prognostic significance and quality of pathology reporting. Cancer 118(3):628–638PubMedCrossRef

Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28(2):264–271PubMedCrossRef

Huh JW, Kim HR, Kim YJ (2010) Lymphovascular or perineural invasion may predict lymph node metastasis in patients with T1 and T2 colorectal cancer. J Gastrointest Surg 14(7):1074–1080PubMedCrossRef

Swanson RS, Compton CC, Stewart AK, Bland KI (2003) The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10(1):65–71PubMedCrossRef

Wohlke M, Schiffmann L, Prall F (2011) Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up. Histopathology 59(5):857–866PubMedCrossRef

Toiyama Y, Miki C, Inoue Y, Tanaka K, Mohri Y, Kusunoki M (2011) Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med 2(1):95–101PubMed

Roxburgh CS, McMillan DC (2010) Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 6(1):149–163PubMedCrossRef

Inoue Y, Iwata T, Okugawa Y et al (2013) Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology 84(2):100–107PubMedCrossRef

10.

Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A (2009) Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 30(7):1073–1081PubMedCrossRef

11.

McPherson R, Pincus MR (2011) Henry’s clinical diagnosis and management by laboratory methods, 22nd edn. Saunders, Philadelphia

12.

Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454PubMedCrossRef

13.

McMillan DC, Watson WS, O’Gorman P, Preston T, Scott HR, McArdle CS (2001) Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 39(2):210–213PubMedCrossRef

14.

Fearon KC, Falconer JS, Slater C, McMillan DC, Ross JA, Preston T (1998) Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response. Ann Surg 227(2):249–254PubMedCrossRef

15.

Andersson C, Lonnroth C, Moldawer LL, Ternell M, Lundholm K (1990) Increased degradation of albumin in cancer is not due to conformational or chemical modifications in the albumin molecule. J Surg Res 49(1):23–29PubMedCrossRef

16.

Lai CC, You JF, Yeh CY et al (2011) Low preoperative serum albumin in colon cancer: a risk factor for poor outcome. Int J Color Dis 26(4):473–481CrossRef

17.

McMillan DC, Crozier JE, Canna K, Angerson WJ, McArdle CS (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881–886CrossRef

18.

Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69PubMedCrossRef

19.

Cengiz O, Kocer B, Surmeli S, Santicky MJ, Soran A (2006) Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma? Med Sci Monit 12(6):CR240–CR247PubMed

20.

Dixon MR, Haukoos JS, Udani SM et al (2003) Carcinoembryonic antigen and albumin predict survival in patients with advanced colon and rectal cancer. Arch Surg 138(9):962–966PubMedCrossRef

21.

Heys SD, Walker LG, Deehan DJ, Eremin OE (1998) Serum albumin: a prognostic indicator in patients with colorectal cancer. J R Coll Surg Edinb 43(3):163–168PubMed

22.

Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047–1051PubMedCrossRef

23.

Kaysen GA (2001) The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol: JASN 12(7):1549–1557PubMed

24.

Kaysen GA (2003) Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int Suppl 87:S92–S98PubMedCrossRef

25.

Sonnenschein C, Soto AM, Michaelson CL (1996) Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol 59(2):147–154PubMedCrossRef

26.

Laursen I, Briand P, Lykkesfeldt AE (1990) Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7. Anticancer Res 10(2A):343–351PubMed

27.

Cohen MH, Makuch R, Johnston-Early A et al (1981) Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer. Cancer Treat Rep 65(3–4):187–195PubMed

28.

Codina Cazador A, Salva Lacombe JA, Fernandez-Llamazares Rodriguez J, Ruiz Feliu B, Codina Barreras A, Moreno Aguado V (1989) Immunoglobulins and the complement system in colorectal cancer. Rev Esp Enferm Apar Dig 75(2):143–148PubMed

29.

Oner F, Savas I, Numanoglu N (2004) Immunoglobulins and complement components in patients with lung cancer. Tuberk Toraks 52(1):19–23PubMed

30.

Shimada H, Nabeya Y, Okazumi S et al (2003) Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 83(4):248–252PubMedCrossRef

31.

Gerhardt T, Milz S, Schepke M et al (2006) C-reactive protein is a prognostic indicator in patients with perihilar cholangiocarcinoma. World J Gastroenterol 12(34):5495–5500PubMed

32.

Canna K, McArdle PA, McMillan DC et al (2005) The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer 92(4):651–654PubMedCrossRef

33.

Osman W, Okada Y, Kamatani Y, Kubo M, Matsuda K, Nakamura Y (2012) Association of common variants in TNFRSF13B, TNFSF13, and ANXA3 with serum levels of non-albumin protein and immunoglobulin isotypes in Japanese. PLoS One 7(4):e32683PubMedCrossRef

34.

Al-Joudi FS (2005) Prognostic value of an index for serum globulin compensation in colon and breast cancers. Singap Med J 46(12):710–713

35.

Hong KW, Jin HS, Song D, Kwak HK, Soo Kim S, Kim Y (2013) Genome-wide association study of serum albumin:globulin ratio in Korean populations. J Hum Genet 58(3):174–177PubMedCrossRef

Title: The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer
Authors: Basem Azab
Shiksha Kedia
Neeraj Shah
Steven Vonfrolio
William Lu
Ali Naboush
Farhan Mohammed
Scott W. Bloom
Publication date: 01-12-2013
Publisher: Springer Berlin Heidelberg
Published in: International Journal of Colorectal Disease / Issue 12/2013
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-013-1748-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The value of the pretreatment albumin/globulin ratio in predicting the long-term survival in colorectal cancer

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 12/2013

Quality colonoscopy and risk of interval cancer in Lynch syndrome

Surgical treatment for isolated inguinal lymph node metastasis in lower rectal adenocarcinoma patients improves outcome

Combination of omentoplasty, trans-abdominal biological mesh, and vacuum-assisted closure system for complex pelvic floor reconstruction. An alternative to current standards?

Descriptive profile of PIK3CA-mutated colorectal cancer in postmenopausal women

Hemi-levator excision to provide greater sphincter preservation in low rectal cancer

Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy